Clinical Trials Browser

Neuroendocrine Tumors × 177Lu-DOTA-JR11 × Clear all

NCT02592707 2023-07-19

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs

Phase 1/2 Terminated

40 enrolled 37 charts

Neuroendocrine Tumors

NCT02609737 2022-02-01

Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors

Phase NA Completed

20 enrolled 8 charts

Neuroendocrine Tumors